(NYSE: MCK) Mckesson's forecast annual revenue growth rate of 7.55% is forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 6.71%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.65%.
Mckesson's revenue in 2025 is $377,595,000,000.On average, 7 Wall Street analysts forecast MCK's revenue for 2026 to be $50,609,257,133,852, with the lowest MCK revenue forecast at $50,098,961,205,893, and the highest MCK revenue forecast at $50,932,781,313,198. On average, 6 Wall Street analysts forecast MCK's revenue for 2027 to be $54,516,056,981,878, with the lowest MCK revenue forecast at $53,859,138,721,601, and the highest MCK revenue forecast at $55,069,199,850,462.
In 2028, MCK is forecast to generate $58,432,071,972,044 in revenue, with the lowest revenue forecast at $58,189,282,841,353 and the highest revenue forecast at $58,676,658,208,445.